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 CURRENTOPINION What’s new in pediatric acute pain therapy?
Anette-Marie Schultz-Machataa, Markus Weissb, and Karin Beckec
Purpose of review
This review highlights the current trends of efficient and safe perioperative pediatric pain therapy in the
context of a multimodal pain therapy concept.
Recent findings
A multimodal pain therapy concept should be easy to apply and safe regarding the occurrence of
side-effects. The administration of nonopioid analgesics should be obligatory, regional anesthesia
techniques – under ultrasound guidance – should be performed whenever possible, opioids should be
given immediately and sufficiently whenever necessary, the administration of co-analgesics like lidocaine,
dexamethasone or ketamine should be considered, and most importantly, each pain therapy should be
performed according to pain assessment and long enough until adequate pain relief.
Summary
Safe and simple pediatric pain management in the perioperative period combines not only easy to apply
and safe stepwise pain therapy itself, but also adequate pain assessment and the implementation of
continuous hospital quality improvement strategies.
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INTRODUCTION
’Pediatric patients seldom need relief of pain after
surgery, they tolerate discomfort well’ [1]. In 1968,
this comment of Swafford and Allen about the
management of postoperative pain in children
unfortunately resulted in poor pain control and
slow development of sufficient pediatric postoper-
ative pain therapy during the following decades.
Thirty years ago, Mather and Mackie [2] reported
that still 40% of postoperative children experienced
moderate or severe pain and that 75% had insuffi-
cient perioperative analgesia prescribed or applied.
Significant painful stimulation without adequate
analgesia will not only cause unacceptable pain at
the time of intervention, it will produce long-lasting
pain memory and behavioral disorders [3–5]. The
structural components necessary to perceive pain
are already present at about 25 weeks of gestation,
so that even our smallest patients are able to
show a graded stress response to any painful stimu-
lation [6–9]. Although there have been several
advantages in intraoperative and postoperative
analgesia in infants and children during the past
years, acute pain is still often undertreated due to
lack of comprehensive acute perioperative pain
management concepts, inadequate pain assess-
ment [10
&&
,11
&&
,12], insufficient knowledge about
age-specific aspects of physiology and pharma-
cology, and the fear of adverse events [13].
Even if it appears that pediatric analgesic use still
remains significantly less than that for adults, a
range of safe and effective pain therapy concepts
have been developed [10
&&
]. The aim of this review is
to illustrate several new important tools for daily
clinical practice to further improve pain relief in the
acute perioperative setting of pediatric surgery.
WHAT ARE THE MOST PAINFUL
PROCEDURES?
The most common surgical interventions during
childhood are simultaneously the most painful in
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context to their low surgical invasivity. Tonsillec-
tomy, appendectomy, orchidopexy, and orthopedic
procedures are described to be more painful than
expected [14]. The pain intensity on the first day
after surgery has recently been investigated in over
50000 patients and published byGerbershagen et al.
[15
&&
]. Surprisingly, beneath the high pain scores
after orthopedic surgery, tonsillectomy and appen-
dectomy are associated with quite similar pain
scores. Up to 44% of children suffered from severe
pain [visual analog scale (VAS) >5] after tonsillec-
tomy on the third postoperative day, and up to 30%
on day 7 [16]. Another publication described similar
pain scores during the first 7 days after tonsillec-
tomy, with many children still experiencing clin-
ically significant levels of pain throughout the
second week of recovery [17
&&
].
Orchidopexy was also unexpectedly associated
with higher pain scores and more prolonged pain
[17
&&
,18] than – for instance – herniotomy. Pain
after appendectomy is comparable to tonsillectomy,
with the laparoscopic approach being at least as
painful as the open procedure [14].
NEW CONCEPTS
There is still a lack of sufficient and adequate pain
relief not only on the day of surgery but also during
the first postoperative days. To counteract pain in
the immediate postoperative period in infants and
children, an adequate multimodal pain therapy
concept for daily clinical practice must be imple-
mented. It should be easy to apply and safe regard-
ing the occurrence of side-effects. Local or regional
anesthesia should be performed whenever possible,
the administration of nonopioid analgesics should
be obligatory after each kind of painful intervention
or surgery, opioids should be given immediately and
sufficiently whenever necessary, the administration
of co-analgesics should be considered, and most
importantly, each pain therapy should be per-
formed according to pain assessment and long
enough until adequate pain relief. Figure 1 shows
an example for multimodal pain therapy in typical
pediatric surgical procedures (’take home receipts’).
REGIONAL ANESTHESIA
The benefit of additional local and regional anes-
thesia for pediatric surgery is a well known concept.
Pediatric regional anesthesia combined with general
anaesthesia is a standard in pediatric anesthesia to
reduce intraoperative opioids and to provide post-
operative pain relief in infants and children. Two
large studies underline the safety of this concept, so
that every child undergoing a surgical intervention
accessible to any kind of regional anesthesia should
get this technique. Polaner et al. [19] evaluated in a
multi-institutional study in the USA approximately
15000 regional blocks in pediatric patients. There
were no deaths or complications with sequelae last-
ing for more than 3 months. Single injection blocks
as well as peripheral techniques had lower compli-
cation rates than continuous blockades and central
regional anesthesia techniques. Ninety-five per cent
of all blocks were performed under general anes-
thesia. Ecoffey et al. [20] described nearly 30000
regional blocks also performed under general anes-
thesia in a 1-year follow-up survey in Europe. The
documented complications (0.12%) were usually
minor and also did not result in any sequelae. The
complication rate was six times higher for central
than for peripheral blocks.
Regional anesthesia may safely be administered
not only under general anesthesia but also under
sedation with spontaneous respiration. Caudal
blockade can be performed for all kinds of subum-
bilical pediatric surgery under sedation with excel-
lent results concerning high success and very low
complication rates [21]. Infants under 1 year nor-
mally do not require additional sedation after suc-
cessful caudal block. In an Austrian study, 76.3% of
all patients were adequately pain and stress-free after
caudal blockade and did not require further sedative
medication during surgery. Ultrasound guidance is a
very helpful tool for peripheral blocks, like trans-
versus abdominis plane (TAP) block, whichmay be a
perfect alternative for pain management of several
minor abdominal surgery interventions, if the
patient’s age is over 10–12 years and therefore
caudal blockade not feasible [22]. Sahin et al. [23]
recently compared TAP block with wound infiltra-
tion in 57 children. TAP block provided prolonged
postoperative analgesia and reduced analgesic use
without any clinical side-effects after inguinal her-
nia repair [23]. Continuous epidural catheterization
KEY POINTS
 Acute perioperative pain in infants and children is still
often undertreated, although there have been several
advantages in intraoperative and postoperative
analgesia during the past decades.
 A modern multimodal perioperative pain therapy
concept must be easy to apply and safe regarding the
occurrence of side-effects.
 To optimize therapy strategies and to improve the
quality of postoperative pain management, the
implementation of pain assessment and continuous
quality improvement strategies is highly recommended.
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under general anesthesia should only be performed
by experienced anesthesiologists in specialized cen-
ters when major thoracic, abdominal or orthopedic
perlvic surgery is planned and sufficient postoper-
ative analgesia is needed the following days [24].
Upper extremity blocks for orthopedic and trauma
surgery under ultrasound guidance are also per-
formed under sedation in some institutions [25,26].
NEW SYSTEMIC PAIN THERAPY
CONCEPTS
Systemic analgesia with paracetamol, metamizol
and NSAIDs is the basis of every kind of analgesia
during any painful procedure. The dosage regimen
as well as the benefits and pitfalls of these drugs
were extensively described in a magnitude of pub-
lications, recently also in an excellent review of
perioperative analgesia in pediatric surgery in this
Journal [10
&&
]. As a small summary of its daily
administration, the authors administer in their
institution – as in several children hospitals in
Europe – ibuprofen 10mg/kg body weight orally
or rectal up to 4 times/day, metamizol 20mg/kg
body weight orally or intravenously up to 3 times/
day, diclofenac 1mg/kg body weight orally, rectal or
intravenously (over 6 years of age) up to 3 times/day,
and paracetamol up to 7.5–15mg/kg body weight
orally, rectal or intravenously up to 4 times/day
(depending on patient’s age) [27,28]. It can be con-
sidered to administer paracetamol, metamizol or
NSAIDs as a preventive medication before the start
of surgery and as a proactive approach continuously
during the whole immediate period until complete
pain relief. Paracetamol has the lowest analgesic
effect in comparison to diclofenac, as described in
a study concerning the opioid-sparing effects of
both drugs [29]. Diclofenac did reduce morphine
consumption after appendectomy, but the co-
administration of paracetamol did not improve this
effect. In contrast to these results, Mireskandari et al.
advise the combination of both to be more effective
than placebo or both substances alone. Diclofenac
was more effective than paracetamol. These results
were underlined by Elia et al., who analyzed data
from 52 randomized placebo-controlled trials in
adults, and evidenced that the combination of
NSAIDs with opioids offer some advantages of the
use of opioids alone. The overall morphine con-
sumption was decreased up to 55%, and also the
incidence of nausea and vomiting and sedation.
Ibuprofen was described asmore effective than para-
cetamol for the management of pain in adults and
children by a large meta-analysis of 85 studies [30].
Important to know is that ibuprofen can be applied
from 4th month of life/6 kg of body weight (rectally
and orally as suspension), whereas diclofenac is
registered for children only from 1 year of age.
If systemic nonopioid analgesics alone or in
combination with regional anesthesia do not pro-
vide sufficient postoperative analgesia, the addition
of a light to moderate opioid analgesic is necessary.
The availability of appropriate and safe substances is
rare: during the past years, deaths were reported
following tonsillectomy in children due to the
administration of intravenous opioids [31]. Genetic
Take home receipts
Pediatric surgery, pediatric urology surgery
Appendectomy
Tonsillectomy
Rescue medication
Caudal block including clonidine 2–3 µg/kg in patients from 3 months of age
Metamizol 20 mg/kg at the end of surgery, max 60 mg/kgBW/24h
Caudal block if possible, alternatively lidocaine i.v. 1.5 mg/kg after induction of anesthesia, 1.5 mg/kg/h during
surgery and the first postoperative hours (monitoring of ECG, blood pressure and SpO2 obligatory)
Metamizol 20 mg/kg at the end of surgery, max 60 mg/kgBW/24h
Intraoperatively supplementary clonidine 2 µg/kg i.v. and dexamethasone 0.15 mg/kg i.v. (max. 4 mg)
Metamizol 20 mg/kg at the end of surgery, max 60 mg/kgBW/24 h + Ibuprofen 10 mg/kg (4x/d)
If a light to moderate analgestic is sufficient: nalbuphine 0.1–0.2 mg/kg i.v. (single dose), 0.1–0.2 mg/kg/h
(continuously i.v.)
If a strong opioid is needed: morphine or piritramid 0.025–0.05–0.1 mg/kg i.v. (single dose). For patient controlled
analgesia: 25 µg/kg (bolus), 2–4–10 µg/kg/h continuously.
FIGURE 1. ‘Take home receipts’ for perioperative multimodal pain therapy in typical pediatric surgical procedures.
Pediatric anesthesia
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variations in the liver microenzyme, CYP2D6, had
been associated with this fatal adverse event.
Opioids metabolized by CYP2D6 include codeine,
tramadol, hydrocodone, and oxycodone. Ultrarapid
metabolizers and some extensive metabolizers of
CYP2D6 produce more active opioid metabolites
resulting in life-threatening adverse effects. Young
and obese children with a history of sleep apnea
are at a higher risk of developing serious opioid-
related respiratory depression. Therefore, codeine is
not further recommended for the administration
in young children [32]. The Pharmacovigilance Risk
Assessment Committee (PRAC) endorses the US
Food and Drug Administration (FDA) recommen-
dation [33
&
] that codeine has only to be used to treat
acute (short-lived) moderate pain in children above
12 years of age [34
&&
,35,36]. Furthermore, codeine
should not be used at all in children (aged below
18 years) who undergo surgery for the adenectomy
or tonsillectomy, as well as in patients with obstruc-
tive sleep apnea, because these patients are more
susceptible to respiratory problems. Tramadol,
another light-to-moderate opioid, has the same risk
profile, even if no deaths are described until now
[37]. Due to this reason and its disagreeable side-
effects like nausea and vomiting, it is also not further
recommended for painmanagement in the immedi-
ate perioperative setting.
NALBUPHINE
Nalbuphinhydrochloride [(2)-17(cyclobutylmethyl)-
4,5a-epoxymorphinan-3,6a,14-triol hydrochloride]
is a light to moderate, semisynthetic opioid analge-
sic, which acts predominately as an agonist at the
k-receptor and as an antagonist at the m-receptor
[38]. Its k-receptor agonism results in additional
considerable sedation, which is a desirable co-effect
in pediatric pain therapy, when pain is associated
with agitation, when postoperative immobilization
is required, or when other causes of discomfort
cannot be excluded. Nalbuphine is only available
for intravenous administration. It can be
administered as a bolus, a continuous infusion,
and patient-controlled analgesia. Nalbuphine is
the nearly ideal opioid for safe pediatric postoper-
ative pain therapy due to its unique pharmacologi-
cal properties and its high safety profile: its analgesic
potency is comparable with that of morphine. Its
‘ceiling effect’ disables on one hand a further
enhancement of analgesia above 0.3–0.4mg/kg
body weight, and on the other hand, this inhibits
the occurrence of central respiratory depression
[39]. Niesters et al. [34
&&
] recently reviewed all case
reports between 1981 and 2012 concerning respir-
atory depression in pediatrics. Fourteen children
between 17 days and 12 years old were documented.
Central respiratory depression occurred after
codeine and morphine, but not after nalbuphine
administration. Even a 10-fold accidental overdose
did not result in clinically relevant respiratory
depression [40,41]. This fact emphasizes the safety
of the substance for pediatric pain therapy. Another
benefit is that nalbuphine is not listed in the nar-
cotics law of Austria, Germany and Switzerland, so it
can be easily administered also by nurses on the
normal ward without delay in case of immediate
pain therapy necessity. A commonly recommended
dosage regimen is shown in Table 1.
CO-ANALGESICS
Lidocaine, ketamine, and dexamethasone may be
added as co-analgesics to each pain therapy concept.
Lidocaine
Another new concept is the co-administration of
intravenous lidocaine during anesthesia to reduce
postoperative pain intensity and intraoperative
opioid consumption. Lidocaine has been considered
as well tolerated for intravenous use because of its
long history of systemic administration as an anti-
arrhythmic drug [42]. McCarty et al. considered in
their review of 16 trials and 395 patients lidocaine
to be well tolerated and advantageous in adult
abdominal surgery. Thirteen of these trials
Table 1. Nalbuphine, intravenous dosage regimen
Preoperative Preoperative pain: fractures 0.1–0.2mg/kg
Intraoperative Short and less painful procedures 0.2mg/kg
Postoperative Bolus dose repetition every 3–4min 0.1–0.2mg/kg (max. 0.3–0.4mg/kg);
single bolus dose max. 5mg (dysphoria)
Continuously (until 6–8 years of age) 0.1 (0.2) mg/kg/h
PCA (over 6–8 years of age) Continuously 0.02/mg/h basal rate; bolus dose 0.02 mg/kg;
lock out 5min. Not more than 18 bolus doses/2 h;
cumulative not more than 0.4 mg/kg
All dosages are mg/kg body weight. PCA, patient-controlled analgesia.
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demonstrated preventive analgesia by intravenous
lidocaine, not associated with a specific regimen
or dosage.
Until now, lidocaine is only investigated in chil-
dren in the laryngeal reflex responses to tracheal
intubation [43], and as an adjunct to propofol to
prevent or reduce injection pain [44,45]. However,
the low-dose co-administration of lidocaine intra-
venously is a promising concept to further reduce
postoperative pain therapy requirements, for
example, in children with open appendectomy,
when caudal block is not possible or contraindicated.
Ketamine
The N-methyl-D-aspartate antagonist ketamine is
often used as an adjunct to reduce pain severity,
even if the evidence for an opioid-sparing effect in
children is less clear, as described recently in the
review of Russell et al. [10
&&
,46]. Dahmani et al. [47]
who investigated 35 randomized, blinded con-
trolled studies, supported these results. The authors
described that systemic ketamine is effective in
decreasing postoperative pain intensity and analge-
sic requirements, but failed to influence early
(6–24h) pain intensity and analgesic requirement.
Whereas ketamine, administered locally, decreased
immediate and early pain intensity and analgesic
requirements, it failed to exhibit a postoperative
opioid-sparing effect [47].
Dexamethasone
Dexamethasone is frequently used in the perioper-
ative setting to reduce the incidence of nausea and
vomiting [48]. A meta-analysis of 24 randomized
controlled trials in 2751 patients emerged several
important findings [49
&
]: single-shot intermediate-
dose dexamethasone (0.11–0.2mg/kg) has opioid-
sparing effects in adults. It also reduces early and late
pain, but heterogeneity was partially explained by
the time of drug administration (preoperative vs.
intraoperative). High-dose dexamethasone (more
than 0.2mg/kg) had opioid-sparing effects and also
decreased pain scores, whereas it was unable to
detect a difference in opioid use for the low-dose
dexamethasone (less than 0.1mg/kg) when given
intraoperatively despite a reduction in late pain at
rest and at movement. Therefore, a single perioper-
ative systemic dexamethasone dose is evidenced to
be used as part of a multimodal pain strategy.
PEDIATRIC POSTOPERATIVE QUALITY
ANALYSIS
To focus treatment and to improve the quality of
postoperative pain therapy, the implementation of
continuous quality improvement strategies has
been recommended [50]. In light of this, a web-
based Germany-wide outcome-oriented project
called Quality Improvement in Postoperative Pain
Management (QUIPS) was developed in 2005, con-
sisting of standardized data acquisition and an
analysis of quality and process indicators [14,51].
QUIPS has clearly shown that outcomes in post-
operative pain therapy are measurable and compar-
able as well as leading to improved care. As a
consequence, an equivalent tool was recently
developed for children called Quality Improve-
ment in Postoperative Pain Management in Infants
(QUIPSI) [52]. QUIPSI is validated in a multicenter
trial in 10 German hospitals. It was shown that
children at least 4 years of age normally can com-
plete the questionnaire [53]. The results of QUIPSI
uncover gaps in the postoperative pain manage-
ment which will help improve the quality in the
postoperative setting. The QUIPSI approach should
be integrated as a daily tool into all pediatric
surgical departments [28]. The German project
has now been transferred to a European project,
called ‘Improvement in postoperative PAIN OUT-
come’ (‘PAIN-OUT’). The overall goal is to improve
clinical care of patients with postoperative pain, in
developed as well as in developing countries. This
is achieved by collecting patient-reported pain out-
comes as well as clinical data in a standardized
procedure, using a questionnaire available in 18
languages. Participating hospitals subsequently
receive online feedback about their results and
benchmarking with other hospitals. Longitudinal
records allow follow-up of changes over time
(www.pain-out.eu).
CONCLUSION
A modern multimodal pain therapy concept for the
immediate postoperative period in infants and chil-
dren should be easy to apply and well tolerated
regarding the occurrence of side-effects. The admin-
istration of nonopioid analgesics has to be obliga-
tory, additional local and regional anesthesia
techniques-preferable under ultrasound guidance-
should be performed whenever possible, opioids
should be given immediately and sufficiently, the
administration of co-analgesics should be con-
sidered, and most importantly, each pain therapy
should be performed according to pain assessment
and long enough until adequate pain relief.
To focus therapy strategies and to improve the
quality of postoperative pain management, the
implementation of continuous quality improve-
ment strategies is recommended. Several web-based
programs have been implemented in the European
Union.
Pediatric anesthesia
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